{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:47:23Z","timestamp":1792025243697,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16464-7","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:51Z","timestamp":1792022871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of regulatory B, T cells and cytokine production with disease stage in non-small cell lung cancer patients: prospective case control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Helal F","family":"Hetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M.","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad Eldin","family":"Nabil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M.","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0607-5508","authenticated-orcid":false,"given":"Hend M.","family":"Esmaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelazeem M.","family":"Algammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.","family":"ElBadre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Alrefai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Elyamany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola A.","family":"Alkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"16464_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4065\/83.5.584","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584\u201394. https:\/\/doi.org\/10.4065\/83.5.584.","journal-title":"Mayo Clin Proc"},{"key":"16464_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/JTO.0b013e3182582a93","volume":"7","author":"O Arrieta","year":"2012","unstructured":"Arrieta O, et al. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure. J Thorac oncology: official publication Int Association Study Lung Cancer. 2012;7:1228\u201334. https:\/\/doi.org\/10.1097\/JTO.0b013e3182582a93.","journal-title":"J Thorac oncology: official publication Int Association Study Lung Cancer"},{"key":"16464_CR3","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.31557\/apjcp.2019.20.6.1927","volume":"20","author":"HF Hetta","year":"2019","unstructured":"Hetta HF, et al. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Asian Pac J Cancer Prev. 2019;20:1927\u201333. https:\/\/doi.org\/10.31557\/apjcp.2019.20.6.1927.","journal-title":"Asian Pac J Cancer Prev"},{"key":"16464_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573399815666190115151500","volume":"8","author":"HF Hetta","year":"2019","unstructured":"Hetta HF, et al. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer. Microrna. 2019;8:206\u201315. https:\/\/doi.org\/10.2174\/1573399815666190115151500.","journal-title":"Microrna"},{"key":"16464_CR5","doi-asserted-by":"publisher","unstructured":"Zahran AM et al. Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices. J Immunol Res. 2021;2021:3241150. https:\/\/doi.org\/10.1155\/2021\/3241150.","DOI":"10.1155\/2021\/3241150"},{"key":"16464_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/jto.0000000000000551","volume":"10","author":"DP Carbone","year":"2015","unstructured":"Carbone DP, Gandara DR, Antonia SJ, Zielinski C. Paz-Ares, L. Non\u2013Small Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy. J Thorac oncology: official publication Int Association Study Lung Cancer. 2015;10:974\u201384. https:\/\/doi.org\/10.1097\/jto.0000000000000551.","journal-title":"J Thorac oncology: official publication Int Association Study Lung Cancer"},{"key":"16464_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00262-020-02704-7","volume":"70","author":"AM Zahran","year":"2021","unstructured":"Zahran AM, Hetta HF, Mansour S, Saad ES, Rayan A. Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study. Cancer Immunol Immunother. 2021;70:733\u201342. https:\/\/doi.org\/10.1007\/s00262-020-02704-7.","journal-title":"Cancer Immunol Immunother"},{"key":"16464_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41390-021-01627-y","volume":"91","author":"AM Zahran","year":"2022","unstructured":"Zahran AM, et al. Regulatory T-cell phenotypes in children with sickle cell disease. Pediatr Res. 2022;91:1203\u20136. https:\/\/doi.org\/10.1038\/s41390-021-01627-y.","journal-title":"Pediatr Res"},{"key":"16464_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jri.2018.07.004","volume":"129","author":"AM Zahran","year":"2018","unstructured":"Zahran AM, Zharan KM, Hetta HF. Significant correlation between regulatory T cells and vitamin D status in term and preterm labor. J Reprod Immunol. 2018;129:15\u201322. https:\/\/doi.org\/10.1016\/j.jri.2018.07.004.","journal-title":"J Reprod Immunol"},{"key":"16464_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3233\/cbm-181368","volume":"22","author":"AM Zahran","year":"2018","unstructured":"Zahran AM, et al. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia. Cancer Biomark. 2018;22:587\u201395. https:\/\/doi.org\/10.3233\/cbm-181368.","journal-title":"Cancer Biomark"},{"key":"16464_CR11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/jgh.12936","volume":"30","author":"HF Hetta","year":"2015","unstructured":"Hetta HF, et al. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology. J Gastroenterol Hepatol. 2015;30:1543\u201351. https:\/\/doi.org\/10.1111\/jgh.12936.","journal-title":"J Gastroenterol Hepatol"},{"key":"16464_CR12","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s00705-016-3015-4","volume":"161","author":"M Mehta","year":"2016","unstructured":"Mehta M, et al. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients. Arch Virol. 2016;161:3161\u20139. https:\/\/doi.org\/10.1007\/s00705-016-3015-4.","journal-title":"Arch Virol"},{"key":"16464_CR13","doi-asserted-by":"publisher","first-page":"112753","DOI":"10.1016\/j.jim.2020.112753","volume":"480","author":"HF Hetta","year":"2020","unstructured":"Hetta HF, et al. T follicular helper and T follicular regulatory cells in colorectal cancer: A complex interplay. J Immunol Methods. 2020;480:112753. https:\/\/doi.org\/10.1016\/j.jim.2020.112753.","journal-title":"J Immunol Methods"},{"key":"16464_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jss.2004.10.004","volume":"124","author":"H Kawaida","year":"2005","unstructured":"Kawaida H, et al. Distribution of CD4 (+) CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res. 2005;124:151\u20137.","journal-title":"J Surg Res"},{"key":"16464_CR15","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.4049\/jimmunol.177.10.7398","volume":"177","author":"AM Miller","year":"2006","unstructured":"Miller AM, et al. CD4\u2009+\u2009CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol. 2006;177:7398\u2013405.","journal-title":"J Immunol"},{"key":"16464_CR16","first-page":"69","volume":"26","author":"EA Hassan","year":"2019","unstructured":"Hassan EA, et al. Regulatory T Cells, IL10 and IL6 in HCV Related Hepatocellular Carcinoma after Transarterial Chemoembolization (TACE). Egypt J Immunol. 2019;26:69\u201378.","journal-title":"Egypt J Immunol"},{"key":"16464_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.humimm.2019.03.014","volume":"80","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, et al. Increased frequency and FOXP3 expression of human CD8(+)CD25(High+) T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma. Hum Immunol. 2019;80:510\u20136. https:\/\/doi.org\/10.1016\/j.humimm.2019.03.014.","journal-title":"Hum Immunol"},{"key":"16464_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2006.04.015","volume":"25","author":"TR Mempel","year":"2006","unstructured":"Mempel TR, et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity. 2006;25:129\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2006.04.015.","journal-title":"Immunity"},{"key":"16464_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lungcan.2011.06.002","volume":"75","author":"H Tao","year":"2012","unstructured":"Tao H, et al. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung cancer (Amsterdam Netherlands). 2012;75:95\u2013101. https:\/\/doi.org\/10.1016\/j.lungcan.2011.06.002.","journal-title":"Lung cancer (Amsterdam Netherlands)"},{"key":"16464_CR20","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1183\/13993003.00176-2014","volume":"46","author":"DS O\u2019Callaghan","year":"2015","unstructured":"O\u2019Callaghan DS, et al. Tumour islet Foxp3\u2009+\u2009T-cell infiltration predicts poor outcome in nonsmall cell lung cancer. Eur Respir J. 2015;46:1762\u201372. https:\/\/doi.org\/10.1183\/13993003.00176-2014.","journal-title":"Eur Respir J"},{"key":"16464_CR21","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3892\/ijo.2015.3196","volume":"47","author":"S Muto","year":"2015","unstructured":"Muto S, et al. Clinical significance of expanded Foxp3(+) Helios(-) regulatory T cells in patients with non-small cell lung cancer. Int J Oncol. 2015;47:2082\u201390. https:\/\/doi.org\/10.3892\/ijo.2015.3196.","journal-title":"Int J Oncol"},{"key":"16464_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2147\/jir.S279912","volume":"14","author":"HF Hetta","year":"2021","unstructured":"Hetta HF, et al. Possible Role of Regulatory B Cells in Different Beh\u00e7et\u2019s Disease Phenotypes and Therapies: First Report from Egypt. J Inflamm Res. 2021;14:737\u201344. https:\/\/doi.org\/10.2147\/jir.S279912.","journal-title":"J Inflamm Res"},{"key":"16464_CR23","doi-asserted-by":"publisher","unstructured":"Hetta HF, et al. Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression. Vaccines (Basel). 2020;8. https:\/\/doi.org\/10.3390\/vaccines8030380.","DOI":"10.3390\/vaccines8030380"},{"key":"16464_CR24","doi-asserted-by":"publisher","unstructured":"Hetta HF, et al. CD19(+) CD24(hi) CD38(hi) Regulatory B Cells and Memory B Cells in Periodontitis: Association with Pro-Inflammatory and Anti-Inflammatory Cytokines. Vaccines (Basel). 2020;8. https:\/\/doi.org\/10.3390\/vaccines8020340.","DOI":"10.3390\/vaccines8020340"},{"key":"16464_CR25","doi-asserted-by":"publisher","first-page":"00136","DOI":"10.15406\/ghoa.2016.05.00136","volume":"5","author":"H Hetta","year":"2016","unstructured":"Hetta H, Elkady A, Tohamy T, Badary M, Regulatory B, Cells. Key Players in Hepatocellular Carcinoma Progression. Gastroenterol Hepatol Open Access. 2016;5:00136.","journal-title":"Gastroenterol Hepatol Open Access"},{"key":"16464_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.it.2012.10.007","volume":"34","author":"F Balkwill","year":"2013","unstructured":"Balkwill F, Montfort A, Capasso M. B regulatory cells in cancer. Trends Immunol. 2013;34:169\u201373. https:\/\/doi.org\/10.1016\/j.it.2012.10.007.","journal-title":"Trends Immunol"},{"key":"16464_CR27","doi-asserted-by":"publisher","first-page":"20383","DOI":"10.1038\/s41598-020-77416-0","volume":"10","author":"FA Abdelwahab","year":"2020","unstructured":"Abdelwahab FA, et al. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus. Sci Rep. 2020;10:20383. https:\/\/doi.org\/10.1038\/s41598-020-77416-0.","journal-title":"Sci Rep"},{"key":"16464_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507:366\u201370. https:\/\/doi.org\/10.1038\/nature12979.","journal-title":"Nature"},{"key":"16464_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.55133\/eji.280105","volume":"28","author":"EH Abd El-Ghani","year":"2021","unstructured":"Abd El-Ghani EH, et al. Regulatory T Cells and IL35 in Chronic Hepatitis C Related Cirrhosis and Hepatocellular Carcinoma. Egypt J Immunol. 2021;28:46\u201352.","journal-title":"Egypt J Immunol"},{"key":"16464_CR30","doi-asserted-by":"publisher","first-page":"582657","DOI":"10.3389\/fimmu.2020.582657","volume":"11","author":"J Shang","year":"2020","unstructured":"Shang J, Zha H, Sun Y. Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer. Front Immunol. 2020;11:582657. https:\/\/doi.org\/10.3389\/fimmu.2020.582657.","journal-title":"Front Immunol"},{"issue":"4","key":"16464_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/0115665232340926241105064739","volume":"25","author":"CL Li","year":"2025","unstructured":"Li CL, Ma XY, Yi P. The Role of Immunotherapy in Lung Cancer Treatment: Current Strategies, Future Directions, and Insights into Metastasis and Immune Microenvironment. Curr Gene Ther. 2025;25(4):453\u201366. https:\/\/doi.org\/10.2174\/0115665232340926241105064739.","journal-title":"Curr Gene Ther"},{"key":"16464_CR32","doi-asserted-by":"publisher","unstructured":"Beigi A, Naghib SM, Matini A, Tajabadi M, Mozafari MR. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm. Curr Gene Ther. 2025;25(2):92\u2013112. https:\/\/doi.org\/10.2174\/0115665232292768240503050508. PMID: 38778601.","DOI":"10.2174\/0115665232292768240503050508"},{"key":"16464_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1634\/theoncologist.2017-0659","volume":"23","author":"O Lababede","year":"2018","unstructured":"Lababede O, Meziane MA. The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams. Oncologist. 2018;23:844\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2017-0659.","journal-title":"Oncologist"},{"key":"16464_CR34","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1158\/0008-5472.CAN-05-3766","volume":"66","author":"S Inoue","year":"2006","unstructured":"Inoue S, Leitner WW, Golding B, Scott D. Inhibitory effects of B cells on antitumor immunity. Cancer Res. 2006;66:7741\u20137.","journal-title":"Cancer Res"},{"key":"16464_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1349-7006.2003.tb01392.x","volume":"94","author":"O Wakabayashi","year":"2003","unstructured":"Wakabayashi O, et al. CD4\u2009+\u2009T cells in cancer stroma, not CD8\u2009+\u2009T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci. 2003;94:1003\u20139.","journal-title":"Cancer Sci"},{"key":"16464_CR36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/cncr.23712","volume":"113","author":"O Kawai","year":"2008","unstructured":"Kawai O, et al. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer. 2008;113:1387\u201395. https:\/\/doi.org\/10.1002\/cncr.23712.","journal-title":"Cancer"},{"key":"16464_CR37","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1349-7006.2007.00558.x","volume":"98","author":"E Kikuchi","year":"2007","unstructured":"Kikuchi E, et al. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci. 2007;98:1424\u201330. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00558.x.","journal-title":"Cancer Sci"},{"key":"16464_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.Ccr-14-1860","volume":"21","author":"GL Beatty","year":"2015","unstructured":"Beatty GL, Gladney WL. Immune escape mechanisms as a guide for cancer immunotherapy. Clin cancer research: official J Am Association Cancer Res. 2015;21:687\u201392. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-1860.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"4","key":"16464_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364. https:\/\/doi.org\/10.1038\/nrc3239.","journal-title":"Nat Rev Cancer"},{"issue":"6230","key":"16464_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8128","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy. Science. 2015;348(6230):56\u201361. https:\/\/doi.org\/10.1126\/science.aaa8128.","journal-title":"Science"},{"key":"16464_CR41","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.Can-12-3450","volume":"73","author":"S Lindner","year":"2013","unstructured":"Lindner S, et al. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 2013;73:2468\u201379. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-3450.","journal-title":"Cancer Res"},{"key":"16464_CR42","doi-asserted-by":"publisher","unstructured":"Zhou J, et al. Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer. J Translational Med. 2014;12. https:\/\/doi.org\/10.1186\/s12967-014-0304-0.","DOI":"10.1186\/s12967-014-0304-0"},{"key":"16464_CR43","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1159\/000491615","volume":"47","author":"HM Wang","year":"2018","unstructured":"Wang HM, et al. Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2018;47:2407\u201319. https:\/\/doi.org\/10.1159\/000491615.","journal-title":"Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol"},{"key":"16464_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221\u201341. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074934.","journal-title":"Annu Rev Immunol"},{"key":"16464_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/ol.2012.815","volume":"4","author":"Y Shigematsu","year":"2012","unstructured":"Shigematsu Y, et al. Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes. Oncol Lett. 2012;4:625\u201330. https:\/\/doi.org\/10.3892\/ol.2012.815.","journal-title":"Oncol Lett"},{"key":"16464_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1158\/2326-6066.CIR-13-0049","volume":"1","author":"BD Choi","year":"2013","unstructured":"Choi BD, et al. Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody. Cancer Immunol Res. 2013;1:163. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0049.","journal-title":"Cancer Immunol Res"},{"key":"16464_CR47","doi-asserted-by":"publisher","first-page":"1132968","DOI":"10.3389\/fonc.2023.1132968","volume":"13","author":"J Deng","year":"2023","unstructured":"Deng J, Zhao S, Zhang X, Jia K, Wang H, Zhou C, He Y. Tumor-infiltrating B cells in non-small cell lung cancer: current insights and future directions. Front Oncol. 2023;13:1132968. https:\/\/doi.org\/10.3389\/fonc.2023.1132968.","journal-title":"Front Oncol"},{"issue":"5","key":"16464_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41571-018-0003-7","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics. Nat Rev Clin Oncol. 2018;15(5):325\u201340. https:\/\/doi.org\/10.1038\/s41571-018-0003-7.","journal-title":"Nat Rev Clin Oncol"},{"key":"16464_CR49","doi-asserted-by":"publisher","unstructured":"Nagalla S, et al. Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol. 2013;14(R34). https:\/\/doi.org\/10.1186\/gb-2013-14-4-r34.","DOI":"10.1186\/gb-2013-14-4-r34"},{"key":"16464_CR50","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.Can-10-4316","volume":"71","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells. Cancer Res. 2011;71:3505\u201315. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-4316.","journal-title":"Cancer Res"},{"key":"16464_CR51","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1593\/neo.11756","volume":"13","author":"A Ruddell","year":"2011","unstructured":"Ruddell A, Harrell MI, Furuya M, Kirschbaum SB, Iritani BM. B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma. Neoplasia (New York N Y). 2011;13:748\u201357.","journal-title":"Neoplasia (New York N Y)"},{"key":"16464_CR52","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.lungcan.2012.04.011","volume":"77","author":"N Erfani","year":"2012","unstructured":"Erfani N, et al. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung cancer. (Amsterdam Netherlands). 2012;77:306\u201311. https:\/\/doi.org\/10.1016\/j.lungcan.2012.04.011.","journal-title":"(Amsterdam Netherlands)"},{"key":"16464_CR53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","volume":"11","author":"A Kessel","year":"2012","unstructured":"Kessel A, et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev. 2012;11:670\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2011.11.018.","journal-title":"Autoimmun Rev"},{"key":"16464_CR54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/08820139.2014.917096","volume":"43","author":"M Zheng","year":"2014","unstructured":"Zheng M, et al. Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis. Immunol Invest. 2014;43:705\u201316. https:\/\/doi.org\/10.3109\/08820139.2014.917096.","journal-title":"Immunol Invest"},{"key":"16464_CR55","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1007\/s13277-015-4538-0","volume":"37","author":"X Wei","year":"2016","unstructured":"Wei X, et al. Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients. Tumour Biol. 2016;37:6581\u20138. https:\/\/doi.org\/10.1007\/s13277-015-4538-0.","journal-title":"Tumour Biol"},{"key":"16464_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1541-7786.Mcr-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol cancer research: MCR. 2006;4:221\u201333. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-05-0261.","journal-title":"Mol cancer research: MCR"},{"key":"16464_CR57","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s12032-010-9645-6","volume":"28","author":"C Su","year":"2011","unstructured":"Su C, Zhou C, Zhou S, Xu J. Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Med Oncol (Northwood Lond Engl). 2011;28:1453\u20137. https:\/\/doi.org\/10.1007\/s12032-010-9645-6.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"key":"16464_CR58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jclinpath-2013-201581","volume":"66","author":"MT Shata","year":"2013","unstructured":"Shata MT, Abdel-Hameed EA, Hetta HF, Sherman KE. Immune activation in HIV\/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). J Clin Pathol. 2013;66:967\u201375. https:\/\/doi.org\/10.1136\/jclinpath-2013-201581.","journal-title":"J Clin Pathol"},{"key":"16464_CR59","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/jnci\/djm083","volume":"99","author":"A Gemma","year":"2007","unstructured":"Gemma A, et al. Use of a Cytokine Gene Expression Signature in Lung Adenocarcinoma and the Surrounding Tissue as a Prognostic Classifier. JNCI: J Natl Cancer Inst. 2007;99:1257\u201369. https:\/\/doi.org\/10.1093\/jnci\/djm083.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"16464_CR60","first-page":"454","volume":"17","author":"H Kita","year":"2011","unstructured":"Kita H, et al. Does postoperative serum interleukin-6 influence early recurrence after curative pulmonary resection of lung cancer? Annals of thoracic and cardiovascular surgery: official. J Association Thorac Cardiovasc Surg Asia. 2011;17:454\u201360.","journal-title":"J Association Thorac Cardiovasc Surg Asia"},{"key":"16464_CR61","first-page":"649","volume":"5","author":"F De Vita","year":"1998","unstructured":"De Vita F, et al. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer. Oncol Rep. 1998;5:649\u201352.","journal-title":"Oncol Rep"},{"key":"16464_CR62","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3892\/mmr.2015.4694","volume":"13","author":"L Wei","year":"2016","unstructured":"Wei L, Wang H, Yang F, Ding Q, Zhao J. Interleukin-17 potently increases non-small cell lung cancer growth. Mol Med Rep. 2016;13:1673\u201380. https:\/\/doi.org\/10.3892\/mmr.2015.4694.","journal-title":"Mol Med Rep"},{"key":"16464_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","volume":"31","author":"N Martin-Orozco","year":"2009","unstructured":"Martin-Orozco N, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31:787\u201398. https:\/\/doi.org\/10.1016\/j.immuni.2009.09.014.","journal-title":"Immunity"},{"key":"16464_CR64","unstructured":"Liu M-X et al. Interleukin-35 suppresses antitumor activity of circulating CD8\u2009+\u2009T cells in osteosarcoma patients. 2019."},{"key":"16464_CR65","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00432-010-0896-6","volume":"137","author":"AL Teixeira","year":"2011","unstructured":"Teixeira AL, et al. Influence of TGFB1\u2009+\u2009869T\u2009>\u2009C functional polymorphism in non-small cell lung cancer (NSCLC) risk. J Cancer Res Clin Oncol. 2011;137:435\u20139. https:\/\/doi.org\/10.1007\/s00432-010-0896-6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16464_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1365-2362.2002.00956.x","volume":"32","author":"N Barthelemy-Brichant","year":"2002","unstructured":"Barthelemy-Brichant N, et al. Increased TGFbeta1 plasma level in patients with lung cancer: potential mechanisms. Eur J Clin Invest. 2002;32:193\u20138.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"16464_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012.","journal-title":"Immunity"},{"issue":"1","key":"16464_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"issue":"7203","key":"16464_CR69","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature"},{"issue":"4","key":"16464_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6(4):295\u2013307. https:\/\/doi.org\/10.1038\/nri1806.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"16464_CR71","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00018-023-04731-2","volume":"80","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang H, Lu L, Wang X, Yang Y, Han J. Autophagy in cancer: mechanisms and therapeutic implications. Cell Mol Life Sci. 2023;80(3):88. https:\/\/doi.org\/10.1007\/s00018-023-04731-2.","journal-title":"Cell Mol Life Sci"},{"key":"16464_CR72","doi-asserted-by":"publisher","first-page":"215784","DOI":"10.1016\/j.canlet.2022.215784","volume":"543","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang S, Li J, Liu T, Zheng S, Yang L. Autophagy and tumor immune microenvironment regulation in cancer progression. Cancer Lett. 2022;543:215784. https:\/\/doi.org\/10.1016\/j.canlet.2022.215784.","journal-title":"Cancer Lett"},{"key":"16464_CR73","doi-asserted-by":"publisher","first-page":"1528230","DOI":"10.3389\/fimmu.2025.1528230","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Wang X, Zhou Y, Zhang J, Liu L, Chen H. Autophagy regulates immune evasion and tumor progression in lung cancer. Front Immunol. 2025;16:1528230. https:\/\/doi.org\/10.3389\/fimmu.2025.1528230.","journal-title":"Front Immunol"},{"key":"16464_CR74","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/ejcdt.ejcdt_144_20","volume":"70","author":"HM Esmaeel","year":"2021","unstructured":"Esmaeel HM, Atta KA, Nabil EE, Naom MA, Ali AH. Factors affecting survival in patients with lung cancer. Egypt J Chest Dis Tuberc. 2021;70:242\u20138. https:\/\/doi.org\/10.4103\/ejcdt.ejcdt_144_20.","journal-title":"Egypt J Chest Dis Tuberc"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16464-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16464-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16464-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:10:58Z","timestamp":1792023058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16464-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16464"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16464-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the faculty of medicine, Sohag University. (Reference number No. Soh.Med-20.12.16)All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all participants in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1226"}}